Aker BioMarine (OB:AKBM) Losses Deepen 15% Annually, Narrative Shifts to Profitability Prospects

Aker BioMarine (OB:AKBM) remains unprofitable, with losses deepening at an average of 15% per year over the past five years. The latest report highlights no turnaround in net profit margin or ...

Instabank (OB:INSTA) Margin Decline Challenges High-Growth Narrative Despite Strong Forecasts

Instabank (OB:INSTA) delivered headline numbers that outpaced the broader Norwegian market, with EPS forecast to grow 24.3% per year and revenue also projected at 24% growth annually. Net profit ...

Komplett (OB:KOMPL): Deep Value Signals as Shares Trade Well Below DCF Fair Value

Komplett (OB:KOMPL) remains unprofitable, but has managed to reduce its losses at an average annual rate of 11.2% over the past five years. With earnings forecast to jump 103.84% per year and ...

Medistim (OB:MEDI) Margin Expansion Reinforces Strong Bullish Narratives Despite Valuation Concerns

Medistim (OB:MEDI) posted headline numbers that reinforce its growth trajectory, with revenue forecast to climb 7.5% per year, handily outpacing the wider Norwegian market’s expected 2.3% growth rate.